DRKS00024187招募中不适用
Therapeutic Targeting of Lyn Kinase with Nilotinib to Treat Chorea-Acanthocytosis - an observational, non-interventional study
Sektion für Translationale Neurodegeneration Albrecht KosselKlinik und Poliklinik für NeurologieUniversitätsmedizin Rostock0 个研究点目标入组 10 人开始时间: 2021年1月25日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 99 Years（—）
- 性别
- All
入选标准
- •Patients suffering from chorea-acanthocytosis (confirmed by chorein western blot and/or genetic testing), off-label therapy with Nilotinib
排除标准
- •not applicable
研究者
相似试验
招募中
不适用
Therapeutic Targeting of Lyn Kinase To Treat Chorea-Acanthocytosis - an observational, non-interventional studyG23.9Degenerative disease of basal ganglia, unspecifiedDRKS00023177Sektion für Translationale Neurodegeneration Albrecht KosselKlinik und Poliklinik für NeurologieUniversitätsmedizin Rostock10
进行中（未招募）
1 期
A muulticenter study to evaluate drug response for the treatment of a white blood cell cancer in early chronic phaseEUCTR2011-002787-25-ITG.I.M.E.M.A. GRUPPO ITALIANO MALATTIE EMATOLOGICHE DELL'ADULTO120
进行中（未招募）
不适用
A multicenter study to evaluate drug response for the treatment of a white blood cell cancer in early chronic phase.EUCTR2007-000597-22-ITG.I.M.E.M.A. GRUPPO ITALIANO MALATTIE EMATOLOGICHE DELL'ADULTO
已完成
3 期
Study of deeper responses in newly diagnosed blood cancer (chronic myeloid leukemia) disease patientsCTRI/2012/10/003047ovartis Healthcare Private Limited
进行中（未招募）
1 期
A Phase II Trial of Nilotinib in the Treatment of Patients with c-KIT Mutated Advanced Acral and Mucosal Melanoma (NICAM) - Nilotinib in the Treatment of c-KIT Mutated Melanoma (NICAM)c-KIT mutated advanced acral or mucosal melanomaMedDRA version: 10 Level: LLT Classification code 10025654 Term: Malignant melanoma of sites other than skinMedDRA version: 10 Level: LLT Classification code 10000583 Term: Acral lentiginous melanomaEUCTR2009-012945-49-GBRoyal Marsden Hosptial Foundation Trust29